BCDA vs PODD · $14.4M cap vs P/E 34, rev $2.07B
Biocardia Inc (BCDA) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
BCDA does not have a complete income-statement cache yet.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
BCDA currently screens at market cap $14.4M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the BCDA and PODD stock pages for the full models.
Not investment advice.